Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali - Video

Published On 2025-05-09T12:00:51+05:30 | Updated On 9 May 2025 5:02 PM IST

Overview

Cancer and chemotherapy-induced anemia (CIA) is a common complication in patients undergoing active chemotherapy, with or without radiation therapy. In this video, Dr Aditya Murali, Senior Consultant, Medical Oncology and Hemato-Oncology at Apollo Hospitals, Bannerghatta Road, Karnataka, presents a real-world case highlighting the challenges and effective management of CIA in a patient with metastatic breast cancer.

He discusses the role of darbepoetin alfa (Cresp) in improving and maintaining hemoglobin levels, enhancing patient tolerance to therapy, and ensuring continuity of cancer treatment. The case involves a 71-year-old woman diagnosed with metastatic carcinoma of the right breast, with confirmed metastases to the lungs, axillary lymph nodes, and bones.

This video offers valuable insights into how CIA can be successfully managed with darbepoetin alfa, providing practical guidance for oncologists in real-world clinical settings.

Speakers

Dr Aditya Murali

Dr. Aditya Murali, MD (General Medicine), DM (Medical Oncology), MRCP, ECMO (Medical Oncology). He is a Senior Consultant in Medical Oncology and Hemato-Oncology at Apollo Hospitals, Bannerghatta Road, Karnataka. With extensive experience in managing complex oncological conditions, Dr. Murali has successfully treated over 500 cases across various cancers including lung cancer, breast cancer, ovarian cancer, lymphomas, and leukemias. His areas of expertise are lung cancer, Hemato-oncology & Bone marrow transplantation, Immuno and Cellular therapies.